Xu Fei, Wu Qiaolan, Li Lei, Gong Jie, Huo Ran, Cui Wenqiang
Department of Geriatric Medicine, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
Front Pharmacol. 2021 Apr 26;12:663776. doi: 10.3389/fphar.2021.663776. eCollection 2021.
Icariside II, an active flavonoid, is extracted from the traditional Chinese medicinal herb . It possesses multiple biological and pharmacological properties, including anti-inflammatory, anticancer, and anti-osteoporotic properties. In recent years, apoptosis has become the hot spot in anticancer therapies. Icariside II exerts positive effects on inducing apoptosis and inhibiting proliferation in various cancers. The antitumorigenic activity of Icariside II was also proven through cell cycle arrest, triggering autophagy, reducing cellular metabolism, and inhibiting cancer metastasis and tumor-associated angiogenesis. Additionally, Icariside II, as a natural product, contributed to a synergistic effect alongside chemotherapeutic drugs. Due to its poor aqueous solubility and permeability, more strategies were developed to improve its therapeutic effects. This review aimed to summarize the chemopreventive properties of Icariside II in solid tumors and reveal its underlying molecular mechanisms.
淫羊藿苷II是一种活性黄酮类化合物,从传统中草药中提取。它具有多种生物学和药理学特性,包括抗炎、抗癌和抗骨质疏松特性。近年来,细胞凋亡已成为抗癌治疗的热点。淫羊藿苷II在诱导各种癌症细胞凋亡和抑制增殖方面发挥着积极作用。淫羊藿苷II的抗肿瘤活性还通过细胞周期阻滞、触发自噬、降低细胞代谢以及抑制癌症转移和肿瘤相关血管生成得到证实。此外,淫羊藿苷II作为一种天然产物,与化疗药物协同发挥作用。由于其水溶性和渗透性较差,人们开发了更多策略来提高其治疗效果。本综述旨在总结淫羊藿苷II在实体瘤中的化学预防特性,并揭示其潜在的分子机制。